EBSCO Clinical Decisions is pleased to announce the availability of Dyna AI for individual subscribers of DynaMedex. Leveraging generative artificial intelligence, Dyna AI delivers evidence-based information to clinicians at the point of care with unprecedented speed and accuracy, now accessible without an institutional subscription. Available on any device, Dyna AI ensures clinicians receive reliable and trusted answers whenever and wherever they need them. Initially launched in July 2024, the mobile capability was introduced in October 2024.
Health Technology Insights: OrderlyMeds Launches HealthTech Platform for Personalized Care
EBSCO Clinical Decisions is at the forefront of transforming clinical decision-making, addressing the growing demand for rapid access to high-quality clinical information. By responsibly deploying generative AI, EBSCO Clinical Decisions addresses modern challenges like cognitive overload and clinician burnout. Dyna AI revolutionizes the industry by offering concise, actionable clinical answers with clear citations of expert-curated, evidence-based information exclusively available from EBSCO Clinical Decisions. Tailored to meet the needs of today’s clinicians, Dyna AI for DynaMedex provides a personalized approach, empowering users to swiftly access the most accurate and relevant information wherever and however they need. This update allows individual clinicians to access trusted DynaMedex information at AI speed, without an institutional subscription.
Health Technology Insights: Circana Snacking Research: Health, Flavor, Innovation Drive Cravings
By responsibly deploying generative AI, EBSCO Clinical Decisions addresses modern challenges like cognitive overload and clinician burnout.
Julia Colpitts, Senior Vice President of Clinical Strategy & Commercial Excellence at EBSCO Clinical Decisions, highlights that Dyna AI supports clinicians at the point of care by alleviating the burden of information search, and instead quickly surfacing the answers they need. “Since the release of Dyna AI for Dynamic Health and DynaMedex in July 2024, we have worked to communicate the important role that Dyna AI can play at the point of care. Dyna AI ensures that clinicians can get the evidence-based, expert-curated information they need quicker than ever before.”
Health Technology Insights: Glucotrack and OneTwo Analytics Partner for Glucose Study
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source – PR Web
